Pallas Health vs HermanRx: Pricing, meds, and shipping compared
Quick verdict: Pallas Health vs HermanRx
Pallas Health and HermanRx both offer clinician-reviewed telehealth weight-loss programs, but they differ most on pricing structure, medication choices, and state delivery logistics. Early verdict: choose Pallas Health if you want clinician access to brand-name GLP-1s plus lower introductory compounded pricing; choose HermanRx if you prefer a single all-inclusive monthly bill with published review and shipping timelines.
See Pallas Health plans and pricing
Overview of both providers
Pallas Health is a 100% online medical weight-loss program where a US-licensed clinician personalizes treatment and may choose FDA-approved Wegovy®, Ozempic®, Zepbound® and Mounjaro® or a compounded semaglutide or tirzepatide prepared in the USA. HermanRx is a U.S. telehealth platform that lists compounded semaglutide with vitamin B12 at $249/month and compounded tirzepatide with B12 at $349/month, both described as all-inclusive with provider review, prescription, medication, ongoing support and free discreet shipping.
Top differences: Pricing model, medication options, and logistics
1. Pricing model and introductory offers
Pallas Health lists compounded semaglutide at $139 for the first month, then $597 every 12 weeks (a $199/month average); compounded tirzepatide starts $179 first month, then $897 every 12 weeks ($299/month average). Pallas also publishes cash-pay prices for FDA-approved brand-name pens. HermanRx lists flat all-inclusive monthly pricing: compounded semaglutide + B12 at $249/month and compounded tirzepatide + B12 at $349/month. Both providers state treatment is cash-pay only.
View HermanRx all-inclusive pricing
2. Medication choices and clinician role
Pallas advertises both routes from one intake: FDA-approved brand-name GLP-1s and clinician-personalized compounded semaglutide or tirzepatide when a brand medication is not the right fit. HermanRx lists compounded GLP-1s with B12 and states it offers both FDA-approved and compounded medications depending on the provider’s recommendation. Both providers note that compounded medications are not FDA-approved.
3. State availability, review timing and shipping
Pallas is 100% online and asynchronous in most states, noting 43 of 50 need no video visit; a video visit is required in seven states plus Washington, D.C. Pallas advertises free expedited and discreet shipping but does not publish a specific review-to-delivery timeline on the supplied evidence. HermanRx states availability in all 50 states, a ~5-minute assessment, roughly 24-hour provider review and roughly 72-hour delivery when prescribed, and free discreet shipping. HermanRx also highlights a published timeline while Pallas emphasizes asynchronous intake in most states.
Side-by-side comparison table
| Criteria | Pallas Health | HermanRx |
|---|---|---|
| Compounded semaglutide price | $139 first month, then $597/12 weeks ($199/mo avg) | $249/month (semaglutide + B12, all-inclusive) |
| Compounded tirzepatide price | $179 first month, then $897/12 weeks ($299/mo avg) | $349/month (tirzepatide + B12, all-inclusive) |
| Brand-name FDA-approved options | Offers Wegovy®, Ozempic®, Zepbound® and Mounjaro® when appropriate | States it offers both FDA-approved and compounded depending on provider |
| States & visit format | 100% online; asynchronous in most states (43 of 50 need no video visit); video required in 7 states + D.C. | Available in all 50 states; describes ~5-minute assessment |
| Review and shipping timeline | Free expedited shipping; no specific timeline published in supplied evidence | ~24h provider review and ~72h delivery if prescribed; free discreet shipping |
| Fees and membership | One all-in plan price; provider care and messaging included; no membership fee | All-inclusive monthly price; no membership fee or separate consultation charge |
Clinical and regulatory notes
Both Pallas Health and HermanRx explicitly state that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Pallas notes that eligibility is determined by a US-licensed clinician and that plan prices are cash-pay only. HermanRx also states no insurance is required and that its listed compounded prices are all-inclusive.
Check Pallas Health clinician options
Support, portal access and guarantees
Pallas advertises clinician review, ongoing check-ins and care-team messaging included in plan price, a self-serve portal, a free companion app and a refund in full if a clinician decides treatment is not right for you. HermanRx describes provider review, ongoing clinical support and a secure patient portal; it also publishes quick review and delivery estimates and 24/7 patient support in its supplied material. Neither provider claims that compounded medications are FDA-reviewed.
Pallas Health vs HermanRx: final thoughts
Overall, Pallas Health centers on clinician choice between brand-name pens and compounded preparations with a low introductory compounded price and clinician-included care, while HermanRx emphasizes predictable all-inclusive monthly billing, published review and delivery timelines, and availability in all 50 states. Consider the three main differences—pricing model, medication options, and logistics—when deciding which fit matters most to you.
Choose Pallas Health if…
You want a clinician who can select between FDA-approved brand-name GLP-1 pens and a per-patient compounded preparation, prefer a lower introductory compounded month price ($139 first month for semaglutide), and value provider care included with no membership fee.
Choose HermanRx if…
You prefer a clear, single all-inclusive monthly price that bundles provider review, medication and shipping ($249/mo for semaglutide + B12 or $349/mo for tirzepatide + B12), availability in all 50 states, and a published ~24h review and ~72h delivery timeline.